Prof Abdool Karim has written an editorial for the NEJM this month highlighting the accumulation of more recent evidence showing lack of efficacy of certain Covid-19 treatments, namely ivermectin and fluvoxamine.

He reminds us that prescribing treatments with no proven benefits can still have harms (side-effects) as well as reduce availability of such medicines for the treatment of other conditions with proven benefit.

Find the full piece on the NEJM website.